TSHA
Taysha Gene Therapies Inc
Price:  
5.02 
USD
Volume:  
1,777,064.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TSHA Stock Forecast & Price Target

TSHA Stock Price Forecast

The average stock forecast for Taysha Gene Therapies Inc (TSHA) in the next 12 months is 13.60 USD. This price target corresponds to an upside of 144.16%. The range of stock forecasts for TSHA is 10.10 - 19.95 USD. Based on the ratings of 18 analysts, the consensus recommendation for TSHA is BUY.
Target Low Average Median High
Price (USD) 10.10 13.60 12.75 19.95
Upside 81.33% 144.16% 128.90% 258.17%

Recommendation Trends

The latest consensus rating for TSHA is "BUY". This is the average recommendation of 18 analysts: 0 strong sell, 0 sell, 1 hold, 11 buy, 6 strong buy. In the previous period, 18 analysts also majorly recommmended "BUY" for TSHA.

TSHA Financial Stock Forecast

Revenue This Year
1.95M
-80.08%
from 9.77M
Revenue Next Year
24.50M
1,158.14%
from 1.95M
EPS This Year
-0.50
45.74%
from -0.34
EPS Next Year
-0.53
6.73%
from -0.50